160 related articles for article (PubMed ID: 26693073)
1. A common variant in MTHFR influences response to chemoradiotherapy and recurrence of rectal cancer.
Nikas JB; Lee JT; Maring ED; Washechek-Aletto J; Felmlee-Devine D; Johnson RA; Smyrk TC; Tawadros PS; Boardman LA; Steer CJ
Am J Cancer Res; 2015; 5(10):3231-40. PubMed ID: 26693073
[TBL] [Abstract][Full Text] [Related]
2. Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy.
Stanojevic A; Spasic J; Marinkovic M; Stojanovic-Rundic S; Jankovic R; Djuric A; Zoidakis J; Fijneman RJA; Castellvi-Bel S; Cavic M
Front Genet; 2023; 14():1299599. PubMed ID: 38288161
[No Abstract] [Full Text] [Related]
3. [Genetic variations in MLH3 and MSH2 genes are associated with the sensitivity and prognosis in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy].
Yang J; Wang X; Zou SM; Li HM; Xiao Q; Feng YR; Huang Y; Feng T; Chen JN; Lin DX; Li YX; Jin J; Tan W
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):433-440. PubMed ID: 29936769
[No Abstract] [Full Text] [Related]
4. Impact of single-nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD-12/PRODIGE-2 phase III trial.
Boige V; Mollevi C; Gourgou S; Azria D; Seitz JF; Vincent M; Bigot L; Juzyna B; Miran I; Gerard JP; Laurent-Puig P
Int J Cancer; 2019 Dec; 145(11):3163-3172. PubMed ID: 31107542
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.
Dreussi E; Cecchin E; Polesel J; Canzonieri V; Agostini M; Boso C; Belluco C; Buonadonna A; Lonardi S; Bergamo F; Gagno S; De Mattia E; Pucciarelli S; De Paoli A; Toffoli G
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608007
[TBL] [Abstract][Full Text] [Related]
6. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and genetic prognostic factors of neoadjuvant chemoradiotherapy efficаcy in personalized treatment of local advanced rectal cancer.
Zvirych VV; Michailovich YI; Gorbach OІ; Khranovska NМ
Wiad Lek; 2020; 73(3):589-596. PubMed ID: 32285840
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in 5-Fluorouracil-related enzymes predict pathologic response after neoadjuvant chemoradiation for rectal cancer.
Nelson B; Carter JV; Eichenberger MR; Netz U; Galandiuk S
Surgery; 2016 Nov; 160(5):1326-1332. PubMed ID: 27423551
[TBL] [Abstract][Full Text] [Related]
9. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation.
Wang C; Xie H; Lu D; Ling Q; Jin P; Li H; Zhuang R; Xu X; Zheng S
Clin Transl Oncol; 2018 Apr; 20(4):448-456. PubMed ID: 29185200
[TBL] [Abstract][Full Text] [Related]
10. SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.
Komlósi V; Hitre E; Pap E; Adleff V; Réti A; Székely E; Bíró A; Rudnai P; Schoket B; Müller J; Tóth B; Ottó S; Kásler M; Kralovánszky J; Budai B
BMC Cancer; 2010 Oct; 10():525. PubMed ID: 20920350
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304).
Ulrich CM; Rankin C; Toriola AT; Makar KW; Altug-Teber Ö; Benedetti JK; Holmes RS; Smalley SR; Blanke CD; Lenz HJ
Cancer; 2014 Nov; 120(21):3329-3337. PubMed ID: 25041994
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and role of methylenetetrahydrofolate reductase 677 C-->T and 1298 A-->C polymorphisms in coronary artery disease in Arabs.
Abu-Amero KK; Wyngaard CA; Dzimiri N
Arch Pathol Lab Med; 2003 Oct; 127(10):1349-52. PubMed ID: 14521457
[TBL] [Abstract][Full Text] [Related]
13. MTHFR C677T Polymorphism is Associated with Tumor Response to Preoperative Chemoradiotherapy: A Result Based on Previous Reports.
Zhao Y; Li X; Kong X
Med Sci Monit; 2015 Oct; 21():3068-76. PubMed ID: 26456456
[TBL] [Abstract][Full Text] [Related]
14.
Huang J; Mei J; Jiang L; Jiang Z; Liu H; Ding F
Biomed Rep; 2014 Mar; 2(2):172-176. PubMed ID: 24649091
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial.
Sclafani F; Chau I; Cunningham D; Peckitt C; Lampis A; Hahne JC; Braconi C; Tabernero J; Glimelius B; Cervantes A; Begum R; Gonzalez De Castro D; Hulkki Wilson S; Eltahir Z; Wotherspoon A; Tait D; Brown G; Oates J; Valeri N
Ann Oncol; 2015 Sep; 26(9):1936-1941. PubMed ID: 26162609
[TBL] [Abstract][Full Text] [Related]
16. Interaction between common folate polymorphisms and B-vitamin nutritional status modulates homocysteine and risk for a thrombotic event.
Yates Z; Lucock M
Mol Genet Metab; 2003 Jul; 79(3):201-13. PubMed ID: 12855226
[TBL] [Abstract][Full Text] [Related]
17. Can an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer?
Xiao L; Yu X; Zhang R; Chang H; Xi S; Xiao W; Zeng Z; Zhang H; Xu R; Gao Y
Oncotarget; 2016 Jun; 7(23):34149-57. PubMed ID: 27167201
[TBL] [Abstract][Full Text] [Related]
18.
Kumari R; Kumar S; Thakur VK; Singh K; Kumar U
J Indian Assoc Pediatr Surg; 2022; 27(6):699-706. PubMed ID: 36714485
[TBL] [Abstract][Full Text] [Related]
19. Association of methylenetetrahydrofolate reductase (MTHFR) rs1801133 (677C>T) gene polymorphism with ischemic stroke risk in different populations: An updated meta-analysis.
Zhao L; Li T; Dang M; Li Y; Fan H; Hao Q; Song D; Lu J; Lu Z; Jian Y; Wang H; Wang X; Wu Y; Zhang G
Front Genet; 2022; 13():1021423. PubMed ID: 36685916
[No Abstract] [Full Text] [Related]
20. A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation.
Terrazzino S; Agostini M; Pucciarelli S; Pasetto LM; Friso ML; Ambrosi A; Lisi V; Leon A; Lise M; Nitti D
Pharmacogenet Genomics; 2006 Nov; 16(11):817-24. PubMed ID: 17047490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
